28 results on '"Fluck, Markus"'
Search Results
2. Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine
3. Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION
4. Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial
5. The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
6. Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
7. Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions
8. Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial
9. Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding
10. 195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding
11. P0301FIT FOR PURPOSE VALIDATION OF A CLINICAL ASSAY FOR THE DETECTION OF SERUM LEVELS OF GALACTOSE-DEFICIENT IMMUNOGLOBULIN A1 (GD-IGA1) IN PATIENTS WITH IGA NEPHROPATHY (IGAN)
12. Enantiomer separation by capillary SFC and GC on chirasil-nickel: observation of unusual peak broadening phenomena
13. Enantiomer separation by complexation SFC on immobilized Chirasil-nickel and Chirasil-zinc
14. Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding.
15. Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
16. The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
17. In vitro and in vivo drug disposition of cilengitide in animals and human
18. In Vitro Characterization of Sarizotan Metabolism: Hepatic Clearance, Identification and Characterization of Metabolites, Drug-Metabolizing Enzyme Identification, and Evaluation of Cytochrome P450 Inhibition
19. 3. Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist
20. Dynamic phenomena involving chiral dimethyl-2,3-pentadienedioate in enantioselective gas chromatography and NMR spectroscopy
21. Determination of enantiomerization barriers by computer simulation of experimental elution profiles obtained by high-performance liquid chromatography on a chiral stationary phase
22. On the enantiomerization barrier of atropisomeric 2,2′,3,3′,4,6′-hexachlorobiphenyl (PCB 132)
23. Toward Unified Enantioselective Chromatography with a Single Capillary Column Coated with Chirasil‐Dex
24. Enantioselektive Trennung von Hexobarbital durch GC, SFC, LC und CEC aneiner mit Chirasil-Dex belegten Kapillarsäule
25. Enantiomer Separation by Capillary SFC and GC on Chirasil-Nickel: Observation of Unusual Peak Broadening Phenomena
26. Separation of the enantiomers of stable atropisomeric polychlorinated biphenyls (PCBs) by multidimensional gas chromatography on Chirasil-Dex
27. Enantiomerization of 2,2?-diisopropylbiphenyl during chiral inclusion gas chromatography: Determination of the rotational energy barrier by computer simulation of dynamic chromatographic elution profiles
28. 3. Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ET A selective antagonist
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.